INTERNATIONAL PATENT: JANUX THERAPEUTICS, INC. FILES APPLICATION FOR "COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARGETING PSMA AND EFFECTOR CELL ANTIGENS"

GENEVA, May 13 -- JANUX THERAPEUTICS, INC. (10955 Vista Sorrento Parkway, Suite 200San Diego, California 92130) filed a patent application (PCT/US2025/053008) for "COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARGETING PSMA AND EFFECTOR CELL ANTIGENS" on Oct 29, 2025. With publication no. WO/2026/096557, the details related to the patent application was published on May 07, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CAMPBELL, David (10955 Vista Sorrento Parkway, Suite 200San Diego, California 92130), DIRAIMONDO, Thomas R. (10955 Vista Sorrento Parkway, Suite 200San Die...